Company Search:
Advanced Search
Sponsored Links
Medmira Inc. Company Snapshot
Medmira Inc. operates in the Diagnostic substances sector. In addition to historical fundamental analyses, the complete report available to purchase compares Medmira Inc. with three other pharmaceutical manufacturers in North America: MYOS RENS Technology Inc of the United States (2017 sales of $526,000.00 ), Iterum Therapeutics PLC of the United States ($508,000.00 ), and Adamas Pharmaceuticals Inc which is also based in the United States ($571,000.00 of which 100% was Pharmaceutical).

Sales Analysis. Sales fell dramatically in 2017: Medmira Inc. reported sales of C$747,344.00 (US$568.33 thousand) for the fiscal year ending July of 2017. This represents a sharp decrease of 66.9% versus 2016, when the company's sales were C$2.26 million.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Medmira Inc.
  Stock Performance Chart for Medmira Inc.
  Stock Data: Recent Stock Performance:
  Current Price (11/16/2018): .02
(Figures in Canadian Dollars)
1 Week 0.0%   13 Weeks 50.0%  
4 Weeks 0.0%   52 Weeks -40.0%  
Medmira Inc. Key Data:
  Ticker: MIR Country: Canada
  Exchanges: VEN Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Diagnostic Substances
  2017 Sales 747,344
(Year Ending Jan 2018).
Employees: N/A
  Currency: Canadian Dollars Market Cap: 9,875,465
  Fiscal Yr Ends: July Shares Outstanding: 658,364,320
  Share Type: Common Closely Held Shares: 477,031,145
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.